跳至主要内容
临床试验/JPRN-UMIN000014077
JPRN-UMIN000014077已完成2 期

Clinical evaluation of efficacy of dose-modified intravenous busulfan in allogeneic hematopoietic stem cell transplantation for hematological malignancy. - Efficacy of dose-modified intravenous busulfan

Kyoto University Hospital, Department of Hematology and Oncology0 个研究点目标入组 40 人开始时间: 2014年6月15日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
16years-old 至 70years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.positive for anti-HIV antibody 2.positive for Hbs antigen 3.active another malignancy 4.uncontrollable psychological disorders 5.uncontrollable active infection 6.positive for donor-specific HLA antibody 7.previous history of hematopoietic stem cell transplantation 8.known hypersensitivity to busulfan 9.pregnant women 10.Patients judged as inappropriate for this study by physicians

研究者

发起方
Kyoto University Hospital, Department of Hematology and Oncology

相似试验